Rockwell Medical Inc.

06/15/2026 | Press release | Distributed by Public on 06/15/2026 14:28

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 12, 2026, Rockwell Medical, Inc. held its 2026 Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:
Proposal One: To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified.
For
Against
Abstain
Broker Non-Votes
Joseph Dawson
9,812,114
869,022
330,731
12,801,839
Joan Lau, Ph.D.
9,890,379
729,615
391,873
12,801,839
Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers.
For
Against
Abstain
Broker Non-Votes
8,232,918
2,682,354
96,595
12,801,839
Proposal Three: To ratify the selection of EisnerAmper LLP as the Company's independent registered public accounting firm for 2026.
For
Against
Abstain
22,996,530
698,744
118,432
Proposal Four: To approve and adopt an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock.
For
Against
Abstain
16,993,038
6,597,036
223,632
Rockwell Medical Inc. published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 15, 2026 at 20:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]